MYC and lymphoma: We observed that adoptively-transferred NK cells significantly delayed MYC-driven lymphomagenesis, and contributed to sustained lymphoma regression post MYC inactivation (Fig. 7), suggesting that MYC-driven lymphomas may be particularly sensitive to NK cell-based therapies.